Find trials
Search tips

Creation of a Longitudinal Biospecimen Repository From Patients With Interstitial Lung Diseases (ILD)

Overview

About this study

To develop a repository of blood, urine and tissue samples from patients with ILD to support future studies into the development of such biomarkers.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Ages 18 years of age or older.
  • Patients with a diagnosis of DILD or any fibrotic disease of the lung OR
  • Patients with PHT.
  • Healthy Individuals.
  • Patients willing to provide written informed consent.

Exclusion Criteria:

  • Unwillingness/unable to give blood samples.
  • Subjects who are pregnant or possibly pregnant base on history of last menstrual period are excluded.
  • Had been on rituximab or other B cell depleted therapy.
  • No history of autoimmune disease (healthy subjects only).
  • No history of lung disease (healthy subjects only).

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 11/2/23. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Eva Carmona Porquera, M.D., Ph.D.

Open for enrollment

Contact information:

Boleyn Andrist CCRP

(507) 284-9946

Andrist.Boleyn@mayo.edu

More information

Publications

Publications are currently not available

More about research at Mayo Clinic

.
CLS-20403056

Mayo Clinic Footer